JPWO2022051537A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022051537A5
JPWO2022051537A5 JP2023514415A JP2023514415A JPWO2022051537A5 JP WO2022051537 A5 JPWO2022051537 A5 JP WO2022051537A5 JP 2023514415 A JP2023514415 A JP 2023514415A JP 2023514415 A JP2023514415 A JP 2023514415A JP WO2022051537 A5 JPWO2022051537 A5 JP WO2022051537A5
Authority
JP
Japan
Prior art keywords
raav
pharmaceutical composition
capsid protein
mir
vegf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540094A5 (https=
JP2023540094A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048917 external-priority patent/WO2022051537A1/en
Publication of JP2023540094A publication Critical patent/JP2023540094A/ja
Publication of JPWO2022051537A5 publication Critical patent/JPWO2022051537A5/ja
Publication of JP2023540094A5 publication Critical patent/JP2023540094A5/ja
Pending legal-status Critical Current

Links

JP2023514415A 2020-09-03 2021-09-02 Kh902(コンベルセプト)の送達のためのアデノ随伴ウイルスおよびその使用 Pending JP2023540094A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063074361P 2020-09-03 2020-09-03
US63/074,361 2020-09-03
US202163179700P 2021-04-26 2021-04-26
US63/179,700 2021-04-26
PCT/US2021/048917 WO2022051537A1 (en) 2020-09-03 2021-09-02 Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof

Publications (3)

Publication Number Publication Date
JP2023540094A JP2023540094A (ja) 2023-09-21
JPWO2022051537A5 true JPWO2022051537A5 (https=) 2024-09-06
JP2023540094A5 JP2023540094A5 (https=) 2024-09-06

Family

ID=80491540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514415A Pending JP2023540094A (ja) 2020-09-03 2021-09-02 Kh902(コンベルセプト)の送達のためのアデノ随伴ウイルスおよびその使用

Country Status (10)

Country Link
US (1) US20230340529A1 (https=)
EP (1) EP4208478A4 (https=)
JP (1) JP2023540094A (https=)
KR (1) KR20230061441A (https=)
AU (1) AU2021336425A1 (https=)
BR (1) BR112023003548A2 (https=)
CA (1) CA3192736A1 (https=)
IL (1) IL300864A (https=)
MX (1) MX2023002695A (https=)
WO (1) WO2022051537A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020006435A (es) 2017-12-19 2021-02-09 Akouos Inc Administracion de anticuerpos terapeuticos mediada por vector de virus adenoasociado (aav) en el oido interno.
IL303317A (en) 2020-12-01 2023-07-01 Akouos Inc ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
AU2024247959A1 (en) * 2023-03-28 2025-10-09 General Medicines Llc Nucleic acid off-switches and methods and uses thereof
WO2024220389A2 (en) * 2023-04-17 2024-10-24 University Of Massachusetts Aav2 variants and uses thereof
CN119656336A (zh) * 2023-09-21 2025-03-21 成都弘基生物科技有限公司 一种重组腺相关病毒在制备治疗与血管新生相关眼病的药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100897379B1 (ko) * 2004-06-08 2009-05-14 쳉두 캉홍 바이오테크놀로지스 코. 리미티드 혈관신생-저해 키메릭 단백질 및 그 사용
AU2014286996A1 (en) * 2013-07-12 2016-01-07 Iveric Bio, Inc. Methods for treating or preventing ophthalmological conditions
EP3134522B1 (en) * 2014-04-25 2021-10-06 University of Massachusetts Recombinant aav vectors useful for reducing immunity against transgene products
US11046955B2 (en) * 2015-04-24 2021-06-29 University Of Massachusetts Modified AAV constructs and uses thereof
DK3471780T3 (da) * 2016-06-16 2020-11-23 Adverum Biotechnologies Inc Behandling af amd med aav2-variant med aflibercept
AU2018227483A1 (en) * 2017-02-28 2019-09-12 Adverum Biotechnologies, Inc. Modified AAV capsids and uses thereof
AU2018350990A1 (en) * 2017-10-18 2020-05-21 Regenxbio Inc. Treatment of ocular diseases and metastatic colon cancer with human post-translationally modified VEGF-Trap
KR102205830B1 (ko) * 2017-10-26 2021-01-21 주식회사 큐로진생명과학 솔루블 VEGFR-1 변이체 cDNA를 함유하는 rAAV를 포함하는 황반변성 치료용 조성물
US11103552B2 (en) * 2018-05-10 2021-08-31 Regeneron Pharmaceuticals, Inc. High concentration VEGF receptor fusion protein containing formulations

Similar Documents

Publication Publication Date Title
Bordet et al. Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives
US11851657B2 (en) Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization
JP7182873B2 (ja) 多重ベクターシステム及びその使用
JP2019000114A (ja) 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター
CA3130515A1 (en) Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
JP2017500060A (ja) 対象の網膜色素上皮において目的のポリヌクレオチドを発現させるための方法および医薬組成物
JP7289306B2 (ja) 網膜障害を治療するための組成物及び方法
US20220332792A1 (en) Adeno-associated virus vector platform for delivery of kh902 (conbercept) and uses thereof
US20260001917A1 (en) Modified adeno-associated virus capsid proteins and methods thereof
US20230057380A1 (en) Recombinant adeno-associated virus for delivery of kh902 (conbercept) and uses thereof
CA3117551A1 (en) Compositions and methods for treating age-related macular degeneration and other diseases
US20230340529A1 (en) Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof
CN114144518A (zh) 用于基因疗法的双亮氨酸拉链激酶抑制剂
JPWO2022076711A5 (https=)
EP4045152A1 (en) Methods for modulating level of expression from gene therapy expression cassette
JPWO2020219933A5 (https=)
JPWO2022051537A5 (https=)
CN112424368A (zh) 用于调节眼内压和颅内压的材料和方法
US12570997B2 (en) Factor H vectors and uses thereof
CN117736274A (zh) 一种腺相关病毒衣壳蛋白及其用途
CN115997012B (zh) Rpe65相关眼睛疾病和障碍的治疗
RU2846105C1 (ru) Аденоассоциированный вирус для доставки kh902 (конберцепта) и его применения
US20230048017A1 (en) Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof
CN118146317A (zh) 一种腺相关病毒衣壳蛋白及其用途
WO2022169863A1 (en) Method of gene delivery to retinal astrocytes